Cargando…

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression

Mostrar otras versiones (1)

The incidence of colorectal cancer (CRC) has remained high in recent years, and 5-fluorouracil (5-FU) is a vital chemotherapeutic agent for its treatment. Our previous study reported that N-myc downstream-regulated gene 4 (NDRG4) plays a tumor-suppressive role in CRC, but the mechanisms associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ruikai, He, Chenxiang, Shen, Liangliang, Wang, Shuai, Shen, Yao, Feng, Fan, Zhang, Jian, Zheng, Jianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456512/ https://www.ncbi.nlm.nih.gov/pubmed/34594423 http://dx.doi.org/10.3892/ol.2021.13043

Ejemplares similares

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2022)

Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
por: Yang, Jingbo, et al.
Publicado: (2022)

Sevoflurane upregulates neuron death process-related Ddit4 expression by NMDAR in the hippocampus
por: Li, Shuai, et al.
Publicado: (2023)

Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer
por: Shen, Yao, et al.
Publicado: (2022)

NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations
por: Narayan, Satya, et al.
Publicado: (2017)

NDRG2 regulates adherens junction integrity to restrict colitis and tumourigenesis
por: Wei, Mengying, et al.
Publicado: (2020)

RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2020)

Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2023)

NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis
por: Shen, Liangliang, et al.
Publicado: (2018)

DDIT4 Novel Mutations in Pancreatic Cancer
por: Ding, Fadian, et al.
Publicado: (2021)

5‐FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1
por: Wang, Nuan, et al.
Publicado: (2020)

Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment
por: Brockmueller, Aranka, et al.
Publicado: (2023)

Overexpression of LINC00551 promotes autophagy-dependent ferroptosis of lung adenocarcinoma via upregulating DDIT4 by sponging miR-4328
por: Peng, Xiong, et al.
Publicado: (2022)

Methylation status of DDIT3 gene in Chronic Myeloid Leukemia
por: Wang, Ya-li, et al.
Publicado: (2010)

DDIT3 Expression in Liposarcoma Development
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014)

DDIT3 antagonizes innate immune response to promote bovine alphaherpesvirus 1 replication via the DDIT3-SQSTM1-STING pathway
por: Wang, Song, et al.
Publicado: (2022)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2017)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

The FUS-DDIT3 Interactome in Myxoid Liposarcoma()
por: Yu, Jamie S.E., et al.
Publicado: (2019)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2
por: Bento, Christoffer, et al.
Publicado: (2009)

NDRG4 stratifies the prognostic value of body mass index in colorectal cancer
por: Zheng, Jianyong, et al.
Publicado: (2015)

Circulating levels of DDIT4 and mTOR, and contributions of BMI, inflammation and insulin sensitivity in hyperlipidemia
por: Pan, Xinyan, et al.
Publicado: (2022)

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU
por: TANG, BO, et al.
Publicado: (2016)

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU
por: Tang, Bo, et al.
Publicado: (2018)

AKT inhibitor suppresses hyperthermia-induced Ndrg2 phosphorylation in gastric cancer cells
por: Tao, Yurong, et al.
Publicado: (2013)

Helicobacter pylori CagA Protein Attenuates 5-Fu Sensitivity of Gastric Cancer Cells Through Upregulating Cellular Glucose Metabolism
por: Gao, Sujie, et al.
Publicado: (2020)

Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization
por: Li, Mengyang, et al.
Publicado: (2018)

Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis
por: Iacovides, Demetris, et al.
Publicado: (2018)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
por: Yang, Guang, et al.
Publicado: (2021)

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020)

Xbp1s-Ddit3 promotes MCT-induced pulmonary hypertension
por: Jiang, Hongxia, et al.
Publicado: (2021)

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU
por: Tang, Bo, et al.
Publicado: (2023)

NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β–NDRG2–PP2A Complex Formation
por: Park, Soojong, et al.
Publicado: (2019)

Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers
por: Cangul, Hakan
Publicado: (2004)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients
por: Chu, Dake, et al.
Publicado: (2015)

miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1
por: Yin, Jie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_df9md8u4f42tijm5kk2emb8fke